Ann Thorac Surg 2007;83:1053-1054
© 2007 The Society of Thoracic Surgeons
Division of Cardiovascular Surgery, The Mayo Clinic, 200 First St, SW, Rochester, MN 55905
|The first 20% of the full text of this article appears below.|
A few years ago Francis Robicsek  asked "is it dead or alive?" regarding size reduction ascending aortoplasty. This article  is evidence that it is indeed alive, although debate continues as to whether or not it should be so. This argument has carried on for more than 3 decades. The obvious question is why?
I will begin by confessing my personal opinion, so that the reader can be wary of bias that may underlie my comments. I am opposed to it. I would argue that there is more to the risk of mechanical failure of the aorta than the Law of LaPlace (ie, the strength of the wall is as important an issue as wall tension) and reduction aortoplasty addresses only the latter. Laboratory investigations performed by ourselves and others have raised concerns regarding the composition, molecular biology, and material properties of the dilated aorta. My aversion for reduction aortoplasty is consonant with the majority view today, although this does not mean it is correct. There remains discussion within my own institution and among my colleagues regarding this matter, with some strong proponents of the technique.
Ann. Thorac. Surg. 2007 83: 1047-1053.
This article has been cited by other articles:
A. Della Corte, M. De Feo, C. Bancone, R. Provenzano, S. Giordano, M. Buonocore, G. Nappi, and M. Cotrufo
Long-term follow-up of reduction ascending aortoplasty with autologous partial wrapping: for which patient is waistcoat aortoplasty best suited?
Interact CardioVasc Thorac Surg, January 1, 2012; 14(1): 56 - 63.
[Abstract] [Full Text] [PDF]
|HOME||HELP||FEEDBACK||SUBSCRIPTIONS||ARCHIVE||SEARCH||TABLE OF CONTENTS|
|ANN THORAC SURG||ASIAN CARDIOVASC THORAC ANN||EUR J CARDIOTHORAC SURG|
|J THORAC CARDIOVASC SURG||ICVTS||ALL CTSNet JOURNALS|